Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer
Clinical trial NCT04778982 · TERMINATED
Trial details
- NCT number
- NCT04778982
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-25
- Primary completion
- 2023-03-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.